| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biomarin Pharmaceutical Inc. (BMRN) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. BMRN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 159.4K | $8.91M | - | |
| VP | 80.0K | $4.47M | - | |
| VP | 55.1K | $3.08M | - | |
| Dir | 49.4K | $2.76M | - | |
| Dir | 46.4K | $2.60M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 25, 2019 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 4,000 | $87.86 | $351,440.00 | -1.2% | |
| Mar 25, 2019 | Fuchs Henry J | President, Worldwide R&D | Sell | 5,932 | $87.86 | $521,185.52 | -4.5% | |
| Mar 25, 2019 | Davis George Eric64 | EVP, General Counsel | Sell | 3,363 | $87.86 | $295,473.18 | -4.5% | |
| Mar 21, 2019 | Ajer Jeffrey Robert58 | EVP, Chief Commercial Officer | Sell | 4,519 | $89.98 | $406,633.95 | -3.9% | |
| Mar 19, 2019 | Davis George Eric64 | EVP, General Counsel | Sell | 7,907 | $93.92 | $742,625.44 | -9.1% | |
| Mar 19, 2019 | Ajer Jeffrey Robert58 | EVP, Chief Commercial Officer | Sell | 3,728 | $93.07 | $346,964.96 | -5.9% | |
| Mar 18, 2019 | Fuchs Henry J | President, Worldwide R&D | Sell | 9,597 | $94.09 | $902,981.73 | -6.6% | |
| Mar 15, 2019 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 4,000 | $94.40 | $377,600.00 | -1.2% | |
| Mar 13, 2019 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 3,000 | $93.42 | $280,253.40 | -0.9% | |
| Mar 12, 2019 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 9,000 | $90.06 | $810,549.90 | -1.4% |